Shares of N4 Pharma PLC (LON: N4P) today fell 4.81% despite the lack of news releases from the specialist pharmaceutical company as buyers and sellers fought to control its stock price.
The last update from the company indicated that it was moving in a different direction in regards to its Nuvec® technology being used to deliver COVID-19 vaccines.
However, the Nuvec® technology has wide applications in delivering novel cancer antigens, which could generate a solid revenue stream for the company in future.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
N4 Pharma is still working on making its Nuvec® technology compatible with the COVID-19 vaccines that are currently being developed given the huge potential that such vaccines possess.
The stock hasn’t done much in recent days as it alternates between gains and losses as investors wait for further updates from the company to inform their future decisions.
N4 Pharma is likely to surge higher on any positive updates in future, while it could plunge lower if the company releases any negative updates.
For now, exercising patience is critical given that the stock is trading largely directionless.
N4 Pharma share price
N4 Pharma shares today fell 4.81% to trade at 6.34p having declined from Thursday’s closing price of 6.66p.
People who read this also read:
